IMNM
Immunome Inc
NASDAQ: IMNM · HEALTHCARE · BIOTECHNOLOGY
$22.95
-3.21% today
Updated 2026-04-29
Market cap
$2.60B
P/E ratio
—
P/S ratio
374.45x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$7 – $28
Volume
1.2M
Immunome Inc (IMNM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,085.00%
ROE
-52.10%
ROA
-29.00%
Debt/equity
0.02x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-7.84M | — | — | — |
| 2019 | $0.00 | $-10.55M | — | — | — |
| 2020 | $0.00 | $-17.12M | — | — | — |
| 2021 | $0.00 | $-24.71M | — | — | — |
| 2022 | $6.63M | $-36.90M | -9.52% | -556.83% | -556.75% |
| 2023 | $14.02M | $-106.81M | 100.00% | -781.35% | -761.92% |
| 2024 | $9.04M | $-292.96M | 100.00% | -3,382.37% | -3,240.38% |
| 2025 | $6.94M | $-212.39M | 57.43% | -3,084.76% | -3,059.99% |